Viability predictive factors of the daughter vesicles in hepatic cystic echinococcosis

BMC Infect Dis. 2024 Jan 3;24(1):43. doi: 10.1186/s12879-023-08937-y.

Abstract

Introduction: Management of cystic echinococcosis (CE) requires knowledge of certain aspects related to the survival of Echinococcus granulosus. The viability of daughter vesicles (DV) is a determining factor in guiding therapeutic indications, particularly for transiently active Cysts type CE3b.

Purpose: To determine the predictive factors of DV viability and its impact on the therapeutic management of CE3b type.

Materials and methods: This is a prospective pilot study with an analytical aim on patients with cystic echinococcosis of the liver type CE2 and CE3b, operated in the General Surgery Department of Habib-Bourguiba Academic Hospital, Sfax-Tunisia for 22 months from March 2018 until December 2019. The unit of the study is the DV. A parasitological study of the DV was done in the parasitology laboratory.

Results: During the study period, 27 (40.9%) of 66 operated CE Disease from 21 patients containing 248 DV were explored. The median viability of DV protoscoleces was 16.7%. In bivariate analysis, factors for viability of DV protoscoleces were: fever, acute cholangitis, hyperbilirubinemia, left liver location, rock water and bilious echinococcal fluid (EF), cyst size ≥ 43 mm, Intracystic pressure ≥ 35 mmHg, DV size ≥ 6.5 mm, volume, number of DV/cyst ≥ 5, and opaque wall (p < 0.05). Predictive factors for the Non-viability of DV were: CE3b type, purulent EF, gelatinous EF. In multivariate analysis, only CE2 type, cyst size ≥ 43 mm, number of DV/cyst ≥ 5 and DV size ≥ 6.5 mm were factors significantly associated with the viability of DV protoscoleces.

Conclusion: CE3b cysts without the criteria of viability of DV protoscoleces may become candidates for the 'Wait-and-Watch' procedure.

Keywords: Daughter vesicles; Echinococcus Infection; Hepatic.

MeSH terms

  • Animals
  • Cysts*
  • Echinococcosis* / parasitology
  • Echinococcosis, Hepatic* / drug therapy
  • Echinococcus granulosus*
  • Echinococcus*
  • Humans
  • Nuclear Family
  • Pilot Projects
  • Prospective Studies